172 related articles for article (PubMed ID: 31764404)
1. Survival advantage associated with metformin usage in hepatocellular carcinoma patients with diabetes mellitus receiving radical resection: a propensity score matching analysis.
Luo CS; Lin Y; Zhou WP; Shi J
Eur J Gastroenterol Hepatol; 2020 Aug; 32(8):1030-1035. PubMed ID: 31764404
[TBL] [Abstract][Full Text] [Related]
2. Association of perioperative use of statins, metformin, and aspirin with recurrence after curative liver resection in patients with hepatocellular carcinoma: A propensity score matching analysis.
Khajeh E; Aminizadeh E; Moghadam AD; Ramouz A; Klotz R; Golriz M; Merle U; Springfeld C; Chang DH; Longerich T; Büchler MW; Mehrabi A
Cancer Med; 2023 Oct; 12(19):19548-19559. PubMed ID: 37737550
[TBL] [Abstract][Full Text] [Related]
3. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
[TBL] [Abstract][Full Text] [Related]
4. Metformin confers risk reduction for developing hepatocellular carcinoma recurrence after liver resection.
Chan KM; Kuo CF; Hsu JT; Chiou MJ; Wang YC; Wu TH; Lee CF; Wu TJ; Chou HS; Lee WC
Liver Int; 2017 Mar; 37(3):434-441. PubMed ID: 27775209
[TBL] [Abstract][Full Text] [Related]
5. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
[TBL] [Abstract][Full Text] [Related]
7. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.
Yang T; Lu JH; Lau WY; Zhang TY; Zhang H; Shen YN; Alshebeeb K; Wu MC; Schwartz M; Shen F
J Hepatol; 2016 Mar; 64(3):583-93. PubMed ID: 26596543
[TBL] [Abstract][Full Text] [Related]
8. Survival Advantage Associated with Metformin Usage in Hepatocellular Carcinoma Patients Receiving Radiotherapy: A Propensity Score Matching Analysis.
Jang WI; Kim MS; Lim JS; Yoo HJ; Seo YS; Han CJ; Park SC; Kay CS; Kim M; Jang HS; Lee DS; Chang AR; Park HJ
Anticancer Res; 2015 Sep; 35(9):5047-54. PubMed ID: 26254406
[TBL] [Abstract][Full Text] [Related]
9. Optimal surgical strategy for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score analysis.
Zhang YF; Le Y; Wei W; Zou RH; Wang JH; OuYang HY; Xiao CZ; Zhong XP; Shi M; Guo RP
Oncotarget; 2016 Jun; 7(25):38845-38856. PubMed ID: 27072577
[TBL] [Abstract][Full Text] [Related]
10. Anatomical Resection But Not Surgical Margin Width Influence Survival Following Resection for HCC, A Propensity Score Analysis.
Lee JW; Lee YJ; Park KM; Hwang DW; Lee JH; Song KB
World J Surg; 2016 Jun; 40(6):1429-39. PubMed ID: 26817652
[TBL] [Abstract][Full Text] [Related]
11. Impact of metformin use on the recurrence of hepatocellular carcinoma after initial liver resection in diabetic patients.
Cho WR; Wang CC; Tsai MY; Chou CK; Liu YW; Wu YJ; Lin MT; Chen KD; Chuang CH; Huang PY; Hu TH; Tsai MC
PLoS One; 2021; 16(3):e0247231. PubMed ID: 33661912
[TBL] [Abstract][Full Text] [Related]
12. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
[No Abstract] [Full Text] [Related]
13. The Impact of Tumor Differentiation on the Prognosis of HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A Propensity Score Matching Analysis.
Shen J; Liu J; Li C; Wen T; Yan L; Yang J
Dig Dis Sci; 2018 Jul; 63(7):1962-1969. PubMed ID: 29736828
[TBL] [Abstract][Full Text] [Related]
14. The impact of thrombocytopenia on prognosis of HBV-related small hepatocellular carcinoma: a propensity score matching analysis.
Peng W; Li C; Zhang X; Wen T; Chen Z
World J Surg Oncol; 2021 Feb; 19(1):46. PubMed ID: 33573630
[TBL] [Abstract][Full Text] [Related]
15. Defining Optimal Surgical Treatment for Recurrent Hepatocellular Carcinoma: A Propensity Score Matched Analysis.
Ma KW; Chok KSH; She WH; Chan ACY; Cheung TT; Dai WC; Fung JYY; Lo CM
Liver Transpl; 2018 Aug; 24(8):1062-1069. PubMed ID: 29451360
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and outcomes of combined hepatocellular carcinoma and cholangiocarcinoma versus hepatocellular carcinoma versus cholangiocarcinoma after surgical resection: a propensity score matching analysis.
Lin CW; Wu TC; Lin HY; Hung CM; Hsieh PM; Yeh JH; Hsiao P; Huang YL; Li YC; Wang YC; Shu CW; Chen YS
BMC Gastroenterol; 2021 Jan; 21(1):20. PubMed ID: 33413162
[TBL] [Abstract][Full Text] [Related]
17. Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma.
Yang SY; Wang CC; Chen KD; Liu YW; Lin CC; Chuang CH; Tsai YC; Yao CC; Yen YH; Hsiao CC; Hu TH; Tsai MC
BMC Cancer; 2021 Jan; 21(1):70. PubMed ID: 33446127
[TBL] [Abstract][Full Text] [Related]
18. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
[TBL] [Abstract][Full Text] [Related]
19. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
[TBL] [Abstract][Full Text] [Related]
20. Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
Cabibbo G; Celsa C; Calvaruso V; Petta S; Cacciola I; Cannavò MR; Madonia S; Rossi M; Magro B; Rini F; Distefano M; Larocca L; Prestileo T; Malizia G; Bertino G; Benanti F; Licata A; Scalisi I; Mazzola G; Di Rosolini MA; Alaimo G; Averna A; Cartabellotta F; Alessi N; Guastella S; Russello M; Scifo G; Squadrito G; Raimondo G; Trevisani F; Craxì A; Di Marco V; Cammà C;
J Hepatol; 2019 Aug; 71(2):265-273. PubMed ID: 30959157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
